Showing results (31-40 of 541) with videos related to
Sort By:
Pageof 55
Pharmacogenetics|August 1, 1995
Comparison of substrate metabolism by wild type CYP2D6 protein and a variant containing methionine, not valine, at position 374C L Crespi, D T Steimel, B W Penman, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Cytochrome P450dbl phenotypes in malignant and benign breast diseaseJ E Pontin, H Hamed, I S Fentiman, et al.Journal of Clinical Periodontology|May 1, 1992
The incidence and severity of nifedipine-induced gingival overgrowthS Barclay, J M Thomason, J R Idle, et al.Cancer Chemotherapy and Pharmacology|January 1, 1990
The effect of route of administration and fractionation of dose on the metabolism of ifosfamideM J Lind, H L Roberts, N Thatcher, et al.Journal of Periodontal Research|September 1, 1993
Disposition of nifedipine in plasma and gingival crevicular fluid in relation to drug-induced gingival overgrowthJ S Ellis, R A Seymour, S Monkman, et al.Cancer Chemotherapy and Pharmacology|January 1, 1995
The kinetics of the auto-induction of ifosfamide metabolism during continuous infusionA V Boddy, M Cole, A D Pearson, et al.Ciba Foundation Symposium|January 1, 1980
Toxicological implications of polymorphic drug metabolismJ C Ritchie, T P Sloan, J R Idle, et al.Human Genetics|March 1, 1995
An inactive cytochrome P450 CYP2D6 allele containing a deletion and a base substitutionA K Daly, J B Leathart, S J London, et al.Clinical Pharmacology and Therapeutics|July 1, 1982
Genetic polymorphism of phenformin 4-hydroxylationN S Oates, R R Shah, J R Idle, et al.Journal of the National Cancer Institute|November 18, 1992
Individual variation in the activation and inactivation of metabolic pathways of cyclophosphamideA V Boddy, Y Furtun, S Sardas, et al.Pageof 55